Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate

被引:24
|
作者
Xiao, EN
Xia, LN
Ferin, M
Wardlaw, SL
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
关键词
interleukin-1; interleukin-6; interleukin-1 receptor antagonist; ACTH; hypothalamic-pituitary-adrenal axis;
D O I
10.1016/S0165-5728(99)00050-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies in the rodent have shown that the cytokine IL-1 can act within the brain to influence peripheral IL-6 secretion. In order to determine if such an interaction occurs in the primate, we have compared the effects of intracerebroventricular vs. intravenous injection of IL-1 beta on the release of IL-6 into the peripheral circulation of the monkey. The effects of i.c.v. IL-1 beta on the release of the IL-1 receptor antagonist (IL-1ra) were studied in parallel. For comparison, we have also measured the release of both IL-6 and IL-1ra into lumbar CSF after i.c.v. IL-1 beta injection. Ten ovariectomized rhesus monkeys with indwelling lateral ventricular and peripheral venous cannulae were studied. Human rIL-1 beta (400 ng) was infused either i.c.v. or i.v. over 30 min and blood samples were collected for IL-6 and IL-1ra measurement by monoclonal human ELISAs. Although both i.c.v. and i.v. IL-1 beta stimulated IL-6 and IL-1ra release into peripheral blood, the stimulation was much more profound after i.c.v, injection (p < 0.001). Peak IL-6 levels were 2010 +/- 590 pg/ml after i.c.v. IL-1 beta compared to 243 +/- 60 pg/ml after i.v. IL-1 beta. Peak IL-1ra levels were 61,310 +/- 16,190 pg/ml after i.c.v. IL-1 beta compared to 18,175 +/- 4270 pg/ml after i.v. IL-1 beta. There was no significant effect of an i.c.v. saline infusion on peripheral IL-6 or IL-1ra levels. In four animals, lumbar CSF was collected 7 h after i.c.v, IL-1 beta injection. The mean concentration of IL-6 in CSF was 103, 570 +/- 13,780 pg/ml after i.c.v. IL-1 beta vs. 224 +/- 190 pg/ml after i.c.v. saline injection; IL-1ra was 47,460 +/- 6290 pg/ml vs. 1040 +/- 550 pg/ml, As expected, both i.c.v. and i.v. IL-beta stimulated ACTH and cortisol release, the stimulation was significantly greater after i.c.v. compared to i.v. administration(p < 0.001). Thus, in the monkey, i.c.v. injection of IL-1 beta stimulates the release of large amounts of IL-6 and IL-1ra into the CSF and the peripheral circulation. Both IL-6 and IL-1ra were released into the peripheral circulation to a much greater extent after i.c.v. compared to i.v. IL-1 beta infusion. These studies provide further support in the primate for a mechanism by which inflammation within the brain could induce a variety of systemic responses. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 50 条
  • [1] INTRACEREBROVENTRICULAR INJECTION OF INTERLEUKIN-1 INDUCES HIGH CIRCULATING LEVELS OF INTERLEUKIN-6
    DESIMONI, MG
    SIRONI, M
    DELUIGI, A
    MANFRIDI, A
    MANTOVANI, A
    GHEZZI, P
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05): : 1773 - 1778
  • [2] Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
    Uludag, Irem Fatma
    Bilgin, Sule
    Zorlu, Yasar
    Tuna, Gamze
    Kirkali, Guldal
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (06): : 457 - 461
  • [3] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [4] INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE
    BEAMER, NB
    COULL, BM
    CLARK, WM
    HAZEL, JS
    SILBERGER, JR
    ANNALS OF NEUROLOGY, 1995, 37 (06) : 800 - 805
  • [5] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [6] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [7] INCREASED CIRCULATING INTERLEUKIN-1 AND INTERLEUKIN-6 AFTER INTRACEREBROVENTRICULAR INJECTION OF LIPOPOLYSACCHARIDE
    GOTTSCHALL, PE
    KOMAKI, G
    ARIMURA, A
    NEUROENDOCRINOLOGY, 1992, 56 (06) : 935 - 938
  • [8] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [9] Intracerebroventricular injection of interleukin-1 suppresses peripheral lymphocyte function in the primate
    Sullivan, GM
    Canfield, SM
    Lederman, S
    Xiao, E
    Ferin, M
    Wardlaw, SL
    NEUROIMMUNOMODULATION, 1997, 4 (01) : 12 - 18
  • [10] Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6
    Daig, R
    Rogler, G
    Aschenbrenner, E
    Vogl, D
    Falk, W
    Gross, V
    Schölmerich, J
    Andus, T
    GUT, 2000, 46 (03) : 350 - 358